Results 1 to 10 of about 11 (10)
Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
Медицинский совет, 2014 The article is devoted to the role of respiratory fluoroquinolones in the treatment of community-acquired pneumonia. Respiratory fluoroquinolones are key in the treatment of the disease as they affect virtually all pathogens of community-acquired ...
A. I. Sinopalnikov
doaj +2 more sources
Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
Медицинский совет, 2014 Community-acquired pneumonia is one of the most common infectious diseases in developed countries. Chronic heart failure is an independent risk factor for unfavorable course and prognosis of community-acquired pneumonia. Objective challenges of clinical,
A. A. Bobylev +3 more
doaj +1 more source
Медицинский совет, 2013 The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.
A. I. Sinopalnikov
doaj +1 more source
Fluoroquinolones in ambulatory surgical practice: whom, when, how?
Амбулаторная хирургия, 2016 The articLe discusses the indications and conditions for the use of fLuoroquinoLones (ciprofloxacin, LevofLoxacin, moxifLoxacin) in surgicaL infections of the skin and soft tissues in ambuLatory patients.
A. V. Golub +2 more
doaj
Klinicheskie aspekty khronicheskikh tservitsitov, assotsiirovannykh s ureai mikoplazmami
Гинекология, 2008 Превалирующее положение среди гинекологических заболеваний занимают воспалительные заболевания органов малого таза (ВЗОМТ), следовательно, они являются наиболее частой причиной нарушения репродуктивного здоровья женщин.
O V Bykovskaya
doaj
Новые показания для новых фторхинолонов: моксифлоксацин при лечении нозокомиальных инфекций
, 2009 Н В Белобородова +4 more
openalex +1 more source
Моксифлоксацин при тяжелой внебольничной пневмонии: первая возможность монотерапии?
, 2021 C. В. Яковлев
openalex